GPX4 and lung carcinoma: miR-101-3p is underexpressed in lung cancer tissues and cells used for promoting proliferation, which is reversed by miR-101-3p overexpression restoring the ferroptosis of lung cancer cells by targeting TBLR1 [27] to downregulate GPX4 [179].